Amgen's Tavneos Linked to 20 Deaths in Japan
Twenty deaths were reported in Japan following the use of Amgen’s drug Tavneos, prompting its local partner Kissei to advise caution among healthcare professionals. The incident could impact investor confidence and regulatory scrutiny for both companies.
Tickers: $AMGN